Diagnostic EGD: Indications, Technique, and Systematic Mucosal Survey

Diagnostic EGD: Indications, Technique, and Systematic Mucosal Survey

By gomdori, MD · Procedure Guide · Updated 2026

Procedure Overview

Diagnostic esophagogastroduodenoscopy (EGD) is the cornerstone investigation for evaluating dyspepsia with alarm features, suspected upper GI bleeding, dysphagia, suspected malabsorption, and surveillance of premalignant conditions. A systematic mucosal survey from oropharynx through the second portion of the duodenum, supplemented by structured biopsy protocols (Sydney for H. pylori, Seattle for Barrett’s), maximizes diagnostic yield while minimizing missed lesions. Procedural success depends on adequate preparation, appropriate sedation depth, and disciplined photo documentation.

≥7 minRecommended withdrawal time (gastric inspection)
28ESGE photo-documentation landmarks
11.5%Missed neoplasia rate within 3 years pre-cancer dx
0.03%Perforation risk (diagnostic EGD)

S1. Indications & Patient Selection

Diagnostic EGD is indicated when symptoms or laboratory findings carry sufficient pre-test probability for a clinically actionable mucosal lesion. Inappropriate use—particularly for uncomplicated functional dyspepsia in patients under 60 with no alarm features—drives healthcare cost and procedural risk without benefit. The American Society for Gastrointestinal Endoscopy (ASGE) and ACG concur that test-and-treat for H. pylori (non-invasive) is the preferred initial strategy below age 60 absent red flags.

Established indications

  • Dyspepsia + alarm features: age ≥60 with new-onset dyspepsia, unintended weight loss >5%, dysphagia, odynophagia, persistent vomiting, iron deficiency anemia, palpable mass, family history of upper GI cancer in first-degree relative.
  • Upper GI bleeding: hematemesis, melena, coffee-ground emesis, or unexplained iron deficiency anemia (after negative colonoscopy in patients ≥40).
  • Dysphagia or odynophagia: structural vs motility evaluation; eosinophilic esophagitis screening (≥6 biopsies from proximal and distal esophagus regardless of endoscopic appearance).
  • Suspected malabsorption: celiac serology positive (tTG-IgA), suspected Whipple’s, giardiasis—duodenal biopsy with ≥4 second-portion + 2 bulb specimens.
  • Surveillance: Barrett’s esophagus (per Seattle protocol), gastric intestinal metaplasia (high-risk subgroups), atrophic gastritis (operative link OLGA/OLGIM staging), familial syndromes (FAP, Peutz-Jeghers, hereditary diffuse gastric cancer).
  • Caustic ingestion: within 12–24 hours; classify Zargar grade for prognosis.
  • Foreign body removal: button batteries (immediate), magnets, sharp objects, food impaction (within 6 hours if complete obstruction).

Relative and absolute contraindications

CategorySpecific scenarioAction
AbsoluteSuspected free perforation, hemodynamic instability without resuscitation, unwilling competent patientPostpone or cancel; resuscitate; obtain consent
RelativeRecent MI <30 days, severe coagulopathy (INR >2.5 or platelets <50k for biopsy), large symptomatic AAA, severe COPDRisk-benefit consultation; reverse coagulopathy if biopsy planned
Cautious-goPregnancy (any trimester if urgent), advanced age, ESRD, chronic anticoagulationProceed if benefits outweigh risk; ASGE anticoagulation algorithm

Anticoagulation management

Diagnostic EGD without biopsy is a low-risk procedure—continue antiplatelets and DOACs. With planned biopsy, hold DOACs 24–48h based on creatinine clearance, hold warfarin to INR <2.0 (or proceed if INR within therapeutic range and biopsy is small-caliber forceps only per ASGE 2022). Aspirin 81 mg can be continued throughout.

S2. Equipment & Pre-Procedure Setup

Patient preparation

  • NPO: solid food ≥6 h, clear liquids ≥2 h (ASA fasting guidelines).
  • Informed consent: discuss perforation, bleeding, aspiration, missed lesion risk, sedation reactions; document.
  • IV access: 20-gauge or larger peripheral IV; supplemental oxygen 2 L/min nasal cannula; capnography mandatory for moderate/deep sedation.
  • Position: left lateral decubitus with chin tucked; bite block; suction at hand.
  • Time-out: confirm patient identity, procedure, allergies, anticoagulation status, prior endoscopy reports.

Endoscope and accessories

EquipmentSpecificationUse
Standard gastroscopeOuter diameter 9–10 mm, 1 working channel (2.8 mm), 4-way deflectionRoutine diagnostic exam
Therapeutic gastroscopeLarger channel (3.7–6 mm), dual channel for hemostasisBleeding intervention, large foreign body
Pediatric/transnasal scopeOuter diameter 4.9–5.8 mmPediatric, unsedated, severe stricture
Image-enhanced endoscopyNBI (Olympus), BLI (Fujifilm), LCI, i-SCAN (Pentax)Vascular pattern enhancement, dysplasia detection
Biopsy forcepsStandard or jumbo (2.8 mm)Mucosal sampling
Chromoendoscopy dyesLugol’s 1.5–3% (esophagus), indigo carmine 0.4%, methylene blue, acetic acid 1.5%SCC screening (Lugol), pit pattern (indigo), Barrett’s (acetic)

Sedation tiers

TierAgents (typical adult)Monitoring
Unsedated / topical onlyLidocaine 10% spray 2–3 puffs pharynxPulse ox
Conscious sedation (moderate)Midazolam 1–2 mg IV + fentanyl 25–50 mcg IV titratedPulse ox, BP, ECG, capnography
Deep sedation (MAC, anesthesiologist)Propofol 10–40 mg IV bolus then 25–75 mcg/kg/minCapnography, BIS optional
General anesthesiaPropofol/remifentanil + LMA or ETTFull anesthesia monitoring

Reversal agents at hand

Naloxone 0.04–0.4 mg IV q2–3min (max 2 mg) for opioid reversal; flumazenil 0.2 mg IV over 15 sec, repeat q1min to max 1 mg for benzodiazepine reversal. Avoid flumazenil in chronic benzodiazepine users (seizure risk).

S3. Technique: Systematic Mucosal Survey

A disciplined, reproducible exam pattern is the single greatest determinant of diagnostic yield. The British Society of Gastroenterology and ESGE quality framework recommend a minimum 7-minute inspection time for the gastric mucosa alone, with 28 photo-documented anatomical landmarks per ESGE 2016 systematic photo-documentation protocol.

EGD anatomical pathway and inspection sequence Sequential map: oropharynx, esophagus (UES, mid, GE junction at 40 cm), stomach (cardia, fundus retroflexion, body, incisura, antrum, pylorus), duodenum (bulb, second portion). Systematic EGD Inspection Pathway Oropharynx15 cm Upper EsophagusUES, 18 cm Mid Esophagus25 cm GE Junction / Z-line~40 cm Cardia42 cm Fundus (retroflex)J-maneuver Body greater curveLake Body lesser curveIncisura angularis AntrumPre-pyloric PylorusChannel Duodenal BulbD1 Second DuodenumD2 — papilla Withdrawal: re-inspect on retreat → focus areas missed during insertion → photo-document 28 landmarksMinimum 7 minutes gastric inspection · NBI/dye on suspicious areas
Systematic anatomical pathway of diagnostic EGD with retroflexion and inspection priorities.

Insertion technique

  1. Oropharyngeal entry: with patient swallowing on cue, gently advance under direct vision through the cricopharyngeus (UES, ~15–18 cm from incisors). Avoid blind pushing—Zenker’s diverticulum or anterior cervical osteophytes can deflect the scope.
  2. Esophagus: insufflate minimally, advance with the lumen centered. Note vascular pattern, mucosal breaks, hiatal hernia, Schatzki ring, and the Z-line position relative to the diaphragmatic pinch.
  3. GE junction documentation: record the distance of the Z-line, hiatal hernia length, and any tongues of salmon-colored mucosa (suspect Barrett’s).
  4. Stomach entry: pass through the cardia, perform gentle insufflation. Lake-suction excess fluid for clear visualization.
  5. Retroflexion in fundus: 180° J-maneuver to inspect the cardia, fundus, and lesser curvature from below. Critical for Cameron lesions, fundic varices, and proximal gastric cancers (10–15% of gastric tumors are missed without retroflexion).
  6. Body and antrum: inspect greater curve rugae, incisura angularis (a “blind spot” requiring deliberate angulation), and antrum.
  7. Pylorus and duodenum: traverse the pylorus en face, evaluate D1 bulb (ulcers, polyps), then advance through the superior duodenal angle to D2 to identify the major papilla.

Withdrawal and second-look

The withdrawal phase is where most lesions are detected. Re-inspect the duodenum, pylorus, antrum, body (both curvatures), incisura, fundus on retroflexion, cardia, and esophagus during withdrawal with deliberate insufflation/deflation to expose folds. Apply NBI or chromoendoscopy on any suspicious area. Photograph the 28 ESGE-recommended landmarks regardless of pathology presence—the photographic record establishes inspection completeness.

S4. Findings Documentation & Biopsy Protocols

Standard classification systems

FindingClassificationApplication
Reflux esophagitisLos Angeles A–DA <5 mm break, B ≥5 mm, C bridging <75% circumference, D ≥75%
Barrett’s esophagus extentPrague C&MC = circumferential length, M = maximal tongue length
Bleeding peptic ulcerForrest Ia–IIIIa spurting, Ib oozing, IIa visible vessel, IIb adherent clot, IIc flat pigment, III clean base
Gastric polyp / superficial neoplasmParis classification0-Ip pedunculated, 0-Is sessile, 0-IIa slightly elevated, 0-IIb flat, 0-IIc depressed, 0-III ulcerated
Gastric ulcerSakita-Miwa A1–S2Active (A1/A2) → Healing (H1/H2) → Scar (S1/S2)
Atrophic gastritis severityOLGA / OLGIMStage 0–IV, stages III–IV high-risk for gastric cancer
Esophageal varicesBaveno (small/medium/large) + red signsRisk stratification for prophylaxis

Biopsy protocols by indication

Sydney Protocol (H. pylori and gastritis)

Five biopsies in separate jars: 2 antrum (greater + lesser curve, 2–3 cm from pylorus), 2 corpus (greater + lesser curve, mid-body), 1 incisura angularis. Allows for OLGA/OLGIM staging and detects patchy H. pylori distribution missed by single-site sampling.

Seattle Protocol (Barrett’s surveillance)

Targeted biopsies of all visible mucosal abnormalities first, then 4-quadrant random biopsies every 1 cm (high-grade dysplasia) or every 2 cm (no dysplasia/low-grade). Each level in a separate jar. Sensitivity for detecting dysplasia is ~50% with 2-cm and ~65% with 1-cm intervals.

Eosinophilic esophagitis

≥6 biopsies divided between proximal and distal esophagus regardless of endoscopic appearance (rings, furrows, exudates may be absent). Histology threshold: ≥15 eosinophils per high-power field.

Celiac disease

≥4 biopsies from second-portion duodenum (descending) plus ≥1–2 from duodenal bulb (D1). Patchy villous atrophy is common; bulb-only or single-site sampling underdiagnoses celiac by 10–15%.

Suspicious gastric lesion or mass

Minimum 6–8 biopsies from edge and base of ulcer; for suspected linitis plastica, deep “well biopsy” technique (multiple biopsies from same site) or EUS-FNA. All gastric ulcers require biopsy regardless of benign appearance—malignancy rate 1–3%.

Specimen handling pearls

Orient esophageal biopsies on filter paper with mucosal surface up; submit each anatomical site in a separately labeled jar. For Barrett’s, label with “GE junction +X cm”. Inadequate orientation or pooled jars compromise pathologist’s ability to grade dysplasia or stage gastritis.

S5. Complications & Sedation Safety

ComplicationIncidence (diagnostic)Management
Sore throat10–60%Reassure; lozenges; resolves <48 h
Mild abdominal distension20–30%CO₂ insufflation reduces; usually self-limited
Cardiopulmonary events (hypoxia, hypotension)0.5–2%Stop procedure; supplemental O₂; reposition; reverse sedation if needed
Bleeding (post-biopsy)0.3%Most self-limited; endoscopic clip, epinephrine injection if persistent
Perforation0.03% (cervical 0.01%, esophageal 0.03%, gastric <0.01%)NPO, broad-spectrum antibiotics, CT with oral contrast, surgical/endoscopic closure
Aspiration pneumonitis<0.5%Suction airway, supplemental O₂, supportive care; antibiotics if pneumonia develops
Sedation-related death1 in 10,000–25,000Resuscitation per ACLS

When to halt and reassess immediately

  • SpO₂ <90% despite supplemental O₂ — pause, reposition, jaw thrust, consider reversal
  • Persistent hypotension SBP <90 — fluids, vasopressor (phenylephrine 50–100 mcg IV), withhold further sedation
  • New chest or back pain post-procedure — chest CT to exclude perforation/pneumomediastinum
  • Crepitus in neck or chest wall — Hamman’s sign — emergent surgical evaluation
  • Ongoing hematemesis — re-scope with hemostatic intervention

Pearl: CO₂ over air

CO₂ insufflation reduces post-procedural bloating by >50% and minimizes risk of pneumoperitoneum if a microperforation occurs. CO₂ is absorbed across the mucosa within minutes, while air can persist and propagate dissection planes if perforation is present. Standard of care for diagnostic and therapeutic upper endoscopy in 2026.

Pitfall: Skipping retroflexion

Failure to retroflex in the gastric fundus misses 10–15% of upper gastric neoplasms, large hiatal hernias, fundic varices, and Cameron lesions in chronic IDA workup. Retroflexion adds <30 seconds and is mandatory regardless of indication.

Diagnostic EGD — Procedure Steps Six-stage surgical stepper for diagnostic esophagogastroduodenoscopy: pre-procedure NPO and sedation, esophageal survey to the Z-line at 40 cm, cardia and fundus retroflexion, body and incisura inspection, antrum, pylorus, and duodenal advance to D2, and slow second-look withdrawal with a minimum 7-minute gastric inspection floor. Each stage lists the key maneuver and its associated safety trigger. Diagnostic EGD — Sequential Procedure Steps Insertion to withdrawal · landmark depth (cm from incisors) · key maneuver · safety trigger 1 Pre-procedure & sedation NPO 6h solids / 2h clears Midazolam 1–2 mg + fentanyl 25–50 mcg IV, capnography on Left lateral, bite block ⚠ Halt if SpO₂ <90% — reverse 2 Esophageal survey UES ~15–18 cm, entry on cue Z-line / GE junction ~40 cm LA grade breaks, Prague C&M Salmon mucosa → Barrett? ⚠ No blind push — Zenker risk 3 Cardia & fundus Cardia ~42 cm, lake-suction 180° J-maneuver retroflexion Cameron lesions, fundic varices Photo cardia rosette ⚠ Skip retroflex → 10–15% miss 4 Body & incisura Greater-curve rugae, both walls Incisura angularis — look twice Wash mucus, NBI suspicious foci Sydney: 2 body + 1 incisura ⚠ Incisura = top missed EGC site 5 Antrum, pylorus & duodenum Pre-pyloric antrum, 2 biopsies Traverse pylorus en face D1 bulb → advance to D2 papilla Celiac: 4 D2 + 2 bulb biopsies ⚠ Don’t stop at D1 — reach D2 6 Withdrawal & second-look Re-inspect on retreat, expose folds Photo 28 ESGE landmarks Aspirate air, remove scope CO₂ over air for less bloating ⚠ ≥7 min gastric inspection floor Quality & safety floor across all steps ≥7 min gastric inspection · mandatory retroflexion · 28-landmark photo record · perforation risk 0.03% Reversal ready: naloxone 0.04–0.4 mg IV · flumazenil 0.2 mg IV · missed neoplasia 11.5% if rushed
Diagnostic EGD — Procedure Steps

S6. Post-Procedure Care & Reporting

Recovery

  • Monitor in recovery 30–60 min; discharge criteria: alert, baseline vitals, ambulating with assistance, no significant pain, voided.
  • NPO until gag reflex returns (usually 1 h post-topical anesthetic).
  • No driving, alcohol, or major decisions for 24 h after sedation.
  • Responsible adult escort required.

Discharge instructions

  • Light diet for 24 h; resume normal diet thereafter.
  • Resume regular medications (including anticoagulation per pre-procedure plan).
  • Return precautions: chest pain, severe abdominal pain, fever >38.5°C, hematemesis, melena, or shortness of breath—immediate ER evaluation.
  • Biopsy results discussed at follow-up visit (typically 1–2 weeks).

Standardized report content (ESGE/ASGE quality indicators)

ElementRequired content
IndicationSpecific clinical question (e.g., “iron deficiency anemia workup, post-negative colonoscopy”)
SedationType, doses, response, complications
Extent of examDistal landmark reached (e.g., “second portion of duodenum”)
Gastric inspection timeDocumented in minutes (≥7 min target)
FindingsAnatomical site, size, classification (LA/Forrest/Paris), photos referenced
InterventionsBiopsies (number, sites, jars), hemostatic therapy, dilation, etc.
DiagnosisEndoscopic impression with differential
RecommendationsPathology pending, follow-up interval, surveillance schedule

When to refer / escalate

  • Suspected malignancy on visual inspection — refer to surgical oncology pending histology
  • Barrett’s with dysplasia — referral for endoscopic eradication therapy (RFA, EMR, ESD)
  • Recurrent or refractory bleeding — interventional radiology or surgery
  • Caustic injury Zargar grade 3a/3b — ICU admission and burn/surgical consult
  • Failed cannulation, intubation, or technical difficulty — refer to high-volume tertiary center

Post-procedure reporting is the part that closes the loop between what experienced clinicians saw and what the next clinician does. The report template forces five fields: scope reach (D2 vs limited), mucosal description by zone (esophagus / GE junction / fundus + retroflexion view / body / incisura / antrum / pylorus / D1 / D2), retained content (fluid, food, bile), biopsy site map (drawn or annotated), and a discrete recommendation (surveillance interval or repeat indication). Seasoned clinicians also document negative findings explicitly — “fundic rosette intact, no varices, normal Z-line at 40 cm” — because absence of a finding documented carries diagnostic weight, whereas a silent absence reads as an unobserved field.

Same-day discharge criteria after diagnostic EGD: fully recovered from sedation (Aldrete ≥9), tolerating oral fluids, ambulatory with escort, vital signs stable for 30+ minutes, no abdominal pain disproportionate to expected, and written post-sedation precautions (no driving for 12-24 hours, no major decisions, no alcohol). Red-flag symptoms requiring return: severe persistent chest or abdominal pain, hematemesis, melena, fever, neck swelling or crepitus, or worsening dyspnea. Pathology turnaround typically 5-10 business days — experienced practitioners close the loop with a personal phone call for any malignant or high-grade dysplasia diagnosis, never delegating that to portal messaging.

Procedural Experience: The Search Discipline That Catches Hidden Lesions

(The content below synthesizes published clinical patterns and expert consensus rather than first-person case reports.)The central conviction is that diagnostic EGD is fundamentally a search procedure, not a passage procedure. In experienced practice, the difference between a 6-minute “quick look” and a disciplined 9-12 minute systematic survey is not technical skill — it is whether experienced clinicians visualized five specific blind spots that account for the majority of missed lesions: the cardia on retroflexion, the high lesser curvature, the incisura on tangent, the antrum-pylorus dynamic, and the duodenal sweep at D2.

Retroflexion Is Where Cancer Hides

The cardia and high lesser curvature require deliberate retroflexion with full insufflation and a slow torque sweep. Experienced practice tells trainees that an EGD without a real retroflexion view (long enough to inspect the entire cardiac rosette circumferentially) is incomplete, regardless of what the report says. Seasoned clinicians look specifically for subtle pallor, mucosal nodularity, type IIc depressions, and absence of the normal rosette folds; any of these triggers narrow-band imaging zoom and targeted biopsy.

The Incisura Is the Single Highest-Yield Site

The angularis incisura sits at the tangent of forward and retroflex views. Experienced practitioners deliberately look at incisura twice — once on forward antrum view with the tip angled up, once on retroflexion from the body. Anything more than minor erythema gets NBI zoom and biopsy. They count this as one of their top three “always do” steps.

Wash, Don’t Hurry Past Mucus

Adherent mucus and bile on the gastric body fold often hide flat lesions; experienced practitioners now routinely instill 200-500 mL of dimethicone-water (sometimes with N-acetylcysteine) via the channel, then re-inspect. The first pass experienced clinicians see is often dirty mucosa; the second pass after washing is where the real diagnosis is made. Experienced practice will rinse and re-inspect a single suspicious field three times if needed — the cost is 60 seconds, the gain can be a 2 cm differentiated adenocarcinoma they would otherwise have walked past.

Biopsy Map, Not Just Random Bites

For Helicobacter and atrophic gastritis surveillance experienced practice uses the updated Sydney protocol modified to OLGA/OLGIM scoring: two antrum (greater + lesser), one incisura, two body (greater + lesser). Seasoned clinicians label each jar in real time and dictate the map into the report so the pathologist knows which fragment is which. For any focal lesion, they take targeted biopsies first, then a separate jar for surveillance background mapping. Random sampling without anatomic labeling is data lost; mapped sampling makes follow-up scope and risk stratification meaningful.

Illustrative Scenario

A patient in their fifties was referred for iron deficiency anemia after a “normal” EGD performed elsewhere two months prior. Initial review of outside images showed limited retroflexion and no incisura tangent view. On the repeat scope the treating clinicians deliberately spent time on the high lesser curvature retroflex view, washed thoroughly with 300 mL dimethicone, then re-inspected. A 12 mm pale flat depressed lesion on the lesser curvature near incisura emerged after washing — Paris IIc, slightly nodular margin. Targeted NBI zoom showed irregular microvascular pattern with demarcation; biopsy returned well-differentiated tubular adenocarcinoma confined to mucosa. ESD achieved en bloc R0 resection with curative criteria. Five-year endoscopic surveillance was negative.

Takeaway: A “normal” prior EGD with limited retroflexion and unwashed mucosa is a yellow flag, not a green light — for any unexplained iron-deficiency anemia or refractory dyspepsia, experienced practice repeats the scope with disciplined search protocol rather than ascribing symptoms elsewhere.

Practice Pattern Refinements vs Standard Technique

  1. 9-12 minute floor for diagnostic EGD inspection time. Endoscopist quality data correlate detection of high-grade IM and early neoplasia with inspection time. The internal minimum is 9 minutes between intubation of esophagus and full withdrawal for diagnostic-intent procedures — never a stopwatch race, never under 7 minutes for any inspection scope.
  2. Mandatory five-point retroflexion sweep. Cardia 360°, fundic rosette, lesser curvature high, incisura tangent, antral hood — each is a separate deliberate maneuver, not a single retroflexion turn. Photo documentation of each view in the report.
  3. Dimethicone wash on any mucus-coated field. If the first pass shows adherent mucus, experienced practitioners instill defoamer and re-inspect; they do not biopsy “through” mucus or skip the field.
  4. OLGIM-style biopsy mapping with named jars. Antrum greater + lesser, incisura, body greater + lesser — five jars labeled by anatomic site. Adds 30 seconds to documentation and gives the pathologist the topographic context that pure “random gastric biopsies × 5” wastes.
Five High-Yield Blind Spots on Diagnostic EGD Anatomic map of the stomach showing five most commonly missed sites with required maneuver and finding pattern. Five Blind Spots — Where Lesions Hide on Diagnostic EGD Each requires a deliberate maneuver beyond the forward sweep esophagus body antrum incisura (tangent) 1 2 3 4 5 1 Cardia (retroflex 360°) Maneuver: full retroflex + torque sweep. Look for pale depression, type IIc, missing rosette folds. 2 High lesser curve (retroflex high) Maneuver: retroflex + push tip up against lesser curve. Most common location for early gastric cancer. 3 Fundic rosette (J-maneuver wash) Maneuver: aspirate fluid, instill dimethicone, J-flex. Inspect rosette folds for fundic gland polyps + GAVE. 4 Incisura tangent (look twice) Maneuver: forward antrum view + retroflex body view. Highest yield site for differentiated EGC + OLGIM IV. 5 Pylorus dynamic + D2 sweep Maneuver: watch pylorus open/close 3-4 cycles; advance past major papilla. Don’t bail at D1 bulb only. Floor: 9-12 min inspection · 5-point retroflex sweep · Dimethicone wash on any mucus field OLGIM biopsy map (antrum G/L + incisura + body G/L) — five named jars, not random
RELATED TOOL
Periprocedural Anticoagulation for Endoscopy — enter the endoscopic procedure, the antithrombotic and the thrombotic risk, and see what BSG/ESGE, ASGE and ACG each state.

S7. Frequently Asked Questions

When is EGD preferred over non-invasive H. pylori testing?
EGD with biopsy is preferred when alarm features are present (age ≥60 with new dyspepsia, weight loss, dysphagia, anemia, melena, family history of upper GI cancer), when H. pylori treatment has failed twice (rescue with culture/sensitivity), or when structural disease is independently suspected. Non-invasive testing (urea breath test, stool antigen) suffices for uncomplicated dyspepsia in patients under 60 without alarm features.
How long should the gastric inspection take?
ESGE and BSG quality standards recommend a minimum of 7 minutes for gastric inspection. Studies show inspection times under 7 minutes correlate with significantly higher rates of missed early gastric cancer, particularly in the lesser curvature, incisura, and fundus on retroflexion. Time-stamped photo documentation provides objective evidence of compliance.
Should anticoagulants be held before diagnostic EGD?
Diagnostic EGD without biopsy is a low-risk procedure—continue all antiplatelets and anticoagulants. With planned biopsy: continue aspirin 81 mg; hold clopidogrel only if cardiology agrees; hold DOACs 24–48 hours based on creatinine clearance; hold warfarin to INR less than 2.0 (or proceed if therapeutic and biopsy is small-caliber forceps). Bridge with heparin only for high thromboembolic risk patients per ACC/CHEST guidance.
What is the missed lesion rate after a normal EGD?
In population studies, approximately 11.5% of gastric cancers diagnosed within 3 years had a prior negative EGD. Risk factors for missed lesions include short inspection time (under 7 minutes), absence of retroflexion, no chromoendoscopy or NBI, low endoscopist volume, and patient factors (poor preparation, retained food). Following the systematic survey protocol with photo-documentation and adequate inspection time minimizes the miss rate.
When are repeat EGDs needed for gastric ulcers?
All gastric ulcers should be biopsied at index endoscopy (≥6–8 biopsies from edge and base) given a 1–3% malignancy rate even with benign appearance. Repeat EGD at 8–12 weeks is recommended for ulcers that were not adequately biopsied initially, ulcers larger than 2 cm, or those with persistent symptoms despite PPI therapy. Duodenal ulcers do not require routine repeat EGD if H. pylori is eradicated and symptoms resolve.
GUIDELINE REFERENCES

Primary guideline documents this article draws on. Links resolve via DOI to the publisher; access may require a subscription.

Leave a Reply

Your email address will not be published. Required fields are marked *